Revance Therapeutics, Inc. files for a $96,000,000 initial public offering on December 31, 2013


On December 31, 2013 Revance Therapeutics, Inc. filed for an inital public offering. The offer amount is listed at $96,000,000.

Offer Details

  • Date: Tuesday, December 31, 2013
  • Symbol: RVNC
  • Offer Amount: $96,000,000

Follow us on Twitter, Facebook and Stocktwits to receive updates on this and other IPOs.

More information on Guru Focus, TradeView

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published.